Evidence map›Paper›PMID 37231215›Full record

ReviewMolecular biology reports2023

Recent advances to Neuroprotection: repurposing drugs against neuroinflammatory disorders.

Wishah Bilal, Muhammad Babar Khawar, Ali Afzal, Arshia Naseer, Syeda Eisha Hamid, Sara Shahzaman, Fareeha Qamar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Wishah Bilal *Institute of Zoology, University of the Punjab, Lahore, Pakistan.
Muhammad Babar Khawar *Applied Molecular Biology and Biomedicine Lab, Department of Zoology, University of Narowal, Narowal, Pakistan. babarkhawar@yahoo.com.ORCID http://orcid.org/0000-0002-1812-0591
Ali Afzal *Molecular Medicine and Cancer Therapeutics Lab, Department of Zoology, Faculty of Sciences & Technology, University of Central Punjab, Lahore, Pakistan.
Arshia Naseer *Institute of Zoology, University of the Punjab, Lahore, Pakistan.
Syeda Eisha HamidMolecular Medicine and Cancer Therapeutics Lab, Department of Zoology, Faculty of Sciences & Technology, University of Central Punjab, Lahore, Pakistan.
Sara ShahzamanMolecular Medicine and Cancer Therapeutics Lab, Department of Zoology, Faculty of Sciences & Technology, University of Central Punjab, Lahore, Pakistan.
Fareeha QamarRawalpindi Medical University, Rawalpindi, Pakistan.
University of Central Punjab · PKUniversity of the Punjab · PKRawalpindi Medical University · PKShowa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell death is a natural mechanism for biological clearance for the maintenance of homeostasis in a dynamic microenvironment of the central nervous system. Stress and various factors can lead to imbalance between cellular genesis and cell death leading to dysfunctionality and a number of neuropathological disorders. Drug repurposing can help bypass development time and cost. A complete understanding of drug actions and neuroinflammatory pathways can lead to effective control of neurodegenerative disorders. This review covers recent advances in various neuroinflammatory pathways understanding, biomarkers, and drug repurposing for neuroprotection.

Indexed as

Neurodegenerative DiseasesNeuroprotectionCentral Nervous SystemDrug RepositioningHumansNeuroinflammatory DiseasesBiomarkersCell deathNeuroinflammationNeuronal lossNeuroprotection

Identifiers

PMID37231215
OpenAlexW4378194514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.